skills/pharmolix/openbiomed/text-based-molecule-editing/Snyk

text-based-molecule-editing

Pass

Audited by Snyk on Mar 25, 2026

Risk Level: LOW

Full Analysis

No issues detected.

Audit Metadata

Risk Level

LOW

Analyzed

Mar 25, 2026, 06:02 AM